195 results
Page 3 of 10
8-K
EX-99.2
07e tm4t3egz6kfxp
4 Nov 21
Caladrius Biosciences Provides Corporate Update and Reports 2021 Third Quarter Financial Results
4:09pm
8-K
EX-99.1
geot0
4 Nov 21
Caladrius Biosciences Provides Corporate Update and Reports 2021 Third Quarter Financial Results
4:09pm
8-K
EX-99.2
ht15w
5 Aug 21
Caladrius Biosciences Reports Second Quarter 2021 Financial Results and Provides Business Update
4:09pm
8-K
EX-99.2
jn2jnek
6 May 21
Caladrius Biosciences Reports First Quarter 2021 Financial Results and Provides Business Update
4:06pm
8-K
EX-99.2
xm5dlc1l9w9
25 Feb 21
Caladrius Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
4:07pm
424B5
pxn 8rkws3n
16 Feb 21
Prospectus supplement for primary offering
4:49pm
424B5
0mcl069snf56pd0bb
16 Feb 21
Prospectus supplement for primary offering
4:46pm
8-K
EX-99.1
ar3kmdvjq8
29 Jan 21
Regulation FD Disclosure
7:58am
8-K
EX-99.1
0xkd07q nkp6edyp
11 Jan 21
Regulation FD Disclosure
4:07pm
8-K
EX-99.1
vp8jpqlmax7b3bd2cg6a
14 Dec 20
Regulation FD Disclosure
8:04am
8-K
EX-99.1
o5of94iqwjw4a5yw2g
28 Jul 20
Caladrius Biosciences Appoints Dr. Michael H. Davidson
8:24am
424B5
xcybdz264yat
26 May 20
Prospectus supplement for primary offering
4:02pm
424B5
fe1 7ahaq26
27 Apr 20
Prospectus supplement for primary offering
7:30am
8-K
EX-99.2
j1tr2f 4y7
5 Mar 20
Caladrius Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
4:07pm
8-K
EX-99.2
j6r9r0
18 Nov 19
Caladrius Biosciences Reports Positive Results for CLBS16 from the ESCaPE-CMD Trial at American Heart Association Scientific Sessions 2019
6:21am